Biotech Values

[mcbio]

As for provenge, the earlier papers by Vuk-Pavlovic showed very weak T cell responses. And as we know, the response was largely against the fusion point of the constructed peptide cassette. I won't deny that provenge has demonstrated some efficacy, but I think we can agree that the mechanism through which that efficacy is manifest depends on a pathway very different than rindo.

Any comments on Bavarian Nordic's potentially improved Provenge? See: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=38279562 .